ArticleBMJ global health2021
Rethinking public health campaigns in the COVID-19 era: a call to improve effectiveness, equity and impact.
Article in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- The impact of the regime change on polio outbreaks in Afghanistan.BMJ global health · 2026Observational
- Article
- Opportunities and barriers arising from the COVID-19 pandemic for health campaign integration across immunizations, neglected tropical diseases, insecticide-treated bed nets, and vitamin A supplementation: A qualitative key informant interview study.PLOS global public health · 2025Article
- Cost of integrated immunization campaigns in Nigeria and Sierra Leone: bottom-up costing studies.BMC health services research · 2024Article
- The global incidence and trends of three common flavivirus infections (Dengue, yellow fever, and Zika) from 2011 to 2021.Frontiers in microbiology · 2024Article
- The Level of Knowledge, Attitudes, and Practices in a Caribbean Colombian Population That Recovered from COVID-19 during the Pandemic.Healthcare (Basel, Switzerland) · 2023Article
- Strengthening clinical development activities and preparedness for vaccine manufacturers from emerging countries: Results of a survey.Vaccine: X · 2023Article
- Promising practices for the collaborative planning of integrated health campaigns from a synthesis of case studies.BMJ global health · 2022Article
- Yellow fever resurgence: An avoidable crisis?NPJ vaccines · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.